Abionyx Pharma SA

10-Year Study

ABNX.PA · Healthcare · FR · Common Stock

Executive Summary: Abionyx Pharma SA has compounded at -7.8% annually over the last 10 years, with a maximum drawdown of 97.6% and an annualized volatility of 141.0%.

1Y CAGR
+223.6%
3Y CAGR
+45.9%
5Y CAGR
+21.4%
10Y CAGR
-7.8%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
97.6%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.28
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.49
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
81.8%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · +218.1%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2017 · -77.9%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
40%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
20260.4-10.58.23.4————————0.5%
20255.04.0-2.3-4.77.1-6.026.6121.1-3.125.6-1.3-7.6218.1%
2024-3.1-13.5-9.37.119.0-6.96.91.8-1.90.87.8-11.9-7.6%
202310.0-0.120.5-22.6-28.3-1.7-1.6-1.0-7.417.0-0.9-0.8-25.2%
2022-6.1-13.712.9-14.0-3.7-21.725.88.0-18.214.90.0-6.9-29.6%
2021-14.6-0.622.19.031.1-30.48.4-7.4-7.156.9107.8-21.1147.2%
202022.861.643.50.22.5-13.9-12.618.9-13.3-9.743.4-0.2193.5%
20198.2-10.9-24.50.63.1-8.3-7.711.8-12.7-30.050.74.5-31.2%
201827.2-16.3-12.59.80.8-2.56.3-2.9-6.0-12.9-2.2-69.1-74.3%
2017-11.00.6-75.2-3.6-6.59.8-8.90.06.49.2-4.5-0.5-77.9%
2016———0.5-2.9-16.7-2.519.9-12.33.36.08.9-0.7%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 141.0%. The dominant macroeconomic risk driver is SHV.US, accounting for 72.8% of variance. Idiosyncratic stock-specific factors contribute 9.5%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-03-0110000
2016-04-0110045.924225028702
2016-05-019758.897818599311
2016-06-018128.587830080367
2016-07-017921.928817451205
2016-08-019494.833524684269
2016-09-018323.765786452353
2016-10-018599.311136624568
2016-11-019115.958668197474
2016-12-019931.113662456944
2017-01-018840.413318025257
2017-02-018897.818599311136
2017-03-012204.3628013777266
2017-04-012123.9954075774967
2017-05-011986.222732491389
2017-06-012181.4006888633753
2017-07-011986.222732491389
2017-08-011986.222732491389
2017-09-012112.514351320321
2017-10-012307.692307692307
2017-11-012204.3628013777266
2017-12-012192.8817451205505
2018-01-012789.896670493685
2018-02-012336.3949483352467
2018-03-012043.6280137772671
2018-04-012243.3983926521237
2018-05-012261.7680826636047
2018-06-012204.3628013777266
2018-07-012342.1354764638345
2018-08-012273.2491389207803
2018-09-012137.772675086108
2018-10-011862.227324913892
2018-11-011820.8955223880596
2018-12-01562.5717566016073
2019-01-01608.49598163031
2019-02-01541.905855338691
2019-03-01409.29965556831223
2019-04-01411.5958668197474
2019-05-01424.22502870264066
2019-06-01389.2078071182549
2019-07-01359.35706084959816
2019-08-01401.8369690011481
2019-09-01350.7462686567164
2019-10-01245.69460390355908
2019-11-01370.264064293915
2019-12-01386.91159586681977
2020-01-01475.3157290470723
2020-02-01768.0826636050517
2020-03-011102.1814006888633
2020-04-011104.4776119402984
2020-05-011132.03214695752
2020-06-01974.7416762342134
2020-07-01851.8943742824339
2020-08-011012.6291618828931
2020-09-01878.3008036739378
2020-10-01793.340987370838
2020-11-011137.7726750861077
2020-12-011135.4764638346726
2021-01-01970.1492537313432
2021-02-01964.4087256027553
2021-03-011177.9563719862226
2021-04-011283.5820895522388
2021-05-011683.1228473019517
2021-06-011171.0677382319172
2021-07-011269.804822043628
2021-08-011175.6601607347875
2021-09-011091.848450057405
2021-10-011712.9735935706083
2021-11-013559.1274397244542
2021-12-012807.118254879448
2022-01-012634.902411021814
2022-02-012273.2491389207803
2022-03-012566.0160734787596
2022-04-012206.6590126291617
2022-05-012123.9954075774967
2022-06-011662.4569460390353
2022-07-012091.8484500574054
2022-08-012259.4718714121695
2022-09-011848.450057405281
2022-10-012123.9954075774967
2022-11-012123.9954075774967
2022-12-011977.0378874856483
2023-01-012174.5120551090695
2023-02-012172.2158438576344
2023-03-012617.6808266360504
2023-04-012025.2583237657861
2023-05-011451.2055109070031
2023-06-011425.9471871412168
2023-07-011402.9850746268655
2023-08-011389.2078071182548
2023-09-011285.878300803674
2023-10-011504.0183696900115
2023-11-011490.2411021814005
2023-12-011478.760045924225
2024-01-011432.8358208955221
2024-02-011239.9540757749712
2024-03-011125.1435132032145
2024-04-011205.5109070034441
2024-05-011435.1320321469575
2024-06-011336.3949483352467
2024-07-011428.2433983926521
2024-08-011453.5017221584385
2024-09-011425.9471871412168
2024-10-011437.4282433983926
2024-11-011549.942594718714
2024-12-011366.2456946039033
2025-01-011435.1320321469575
2025-02-011492.5373134328356
2025-03-011458.0941446613087
2025-04-011389.2078071182548
2025-05-011487.9448909299656
2025-06-011398.3926521239953
2025-07-011770.3788748564866
2025-08-013915.0401836969
2025-09-013794.4890929965554
2025-10-014764.638346727899
2025-11-014701.492537313432
2025-12-014345.579793340988
2026-01-014362.801377726751
2026-02-013903.5591274397243
2026-03-014225.028702640642
2026-04-014368.541905855338
Annual Return Matrix
YearAnnual Return
2017-0.7791907514450868
2018-0.743455497382199
2019-0.31224489795918364
20201.9347181008902075
20211.472194135490394
2022-0.2957055214723926
2023-0.2520325203252032
2024-0.07608695652173925
20252.1806722689075633
20260.005284015852047519
Total Factor Risk
1.409836915547646
VTI.US Exposure
0.013731739565385192
VEA.US Exposure
-0.003762729352044213
VWO.US Exposure
0.00718640903869727
QQQ.US Exposure
0.0027679262013244757
VTV.US Exposure
0.04239547346738177
IJR.US Exposure
-0.0022865392472215017
QUAL.US Exposure
0.009799853240854329
SHV.US Exposure
0.7276002413933824
TLT.US Exposure
-0.009176933622471406
LQD.US Exposure
0.08823221758668331
HYG.US Exposure
0.0012876188319585619
GLD.US Exposure
-0.0000311651388786734
USO.US Exposure
0.007131986616262859
VNQ.US Exposure
-0.00022742611672737223
BTC-USD.CC Exposure
0.0054847173378471895
CPER.US Exposure
-0.0008367777476364893
VIX.INDX Exposure
-0.0006754182504057029
UUP.US Exposure
-0.0005328823931284718
TIP.US Exposure
0.016883613772194925
Idiosyncratic Exposure
0.09502807481654164
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
141.0%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$130.3M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+10.2%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+16.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
23.9% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.67
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Abionyx Pharma SA a high-risk investment?

Abionyx Pharma SA (ABNX.PA) has an annualized volatility of 141.0% and experienced a maximum drawdown of 97.6% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of ABNX.PA?

Over the past 10 years, ABNX.PA has generated a Compound Annual Growth Rate (CAGR) of -7.8%. It has had a positive return in 40% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Abionyx Pharma SA

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest